21st.BIO
Overview
21st.BIO is a Danish venture capital firm specializing in early-stage investments in the biotechnology sector. The firm focuses on supporting companies that develop sustainable bio-based alternatives across various industries, including food, materials, and agriculture. By leveraging advanced biotechnological processes, 21st.BIO aims to facilitate the transition towards more sustainable production methods. The firm's investment strategy centers on identifying and nurturing innovative biotech startups that align with its mission of promoting sustainability. 21st.BIO provides not only financial backing but also technical expertise to help portfolio companies optimize their production processes. This support is crucial for scaling up operations and achieving commercial viability in the competitive biotech industry. Since its inception, 21st.BIO has demonstrated a commitment to fostering growth in the biotech sector by investing in companies that offer promising solutions to global challenges. The firm's approach combines strategic investment with a focus on sustainability, positioning it as a key player in advancing the biotech industry's contribution to a more sustainable future.
Investment Focus
- Companies specializing in precision fermentation technology
- Start-ups and established manufacturers in the biotech sector
- Innovations in sustainable protein production
- Projects with potential for large-scale industrial application
- Collaborations aiming to bridge the gap between lab success and market-ready products
Portfolio Companies
Reach 21st.BIO directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about 21st.BIO
What sectors does 21st.BIO invest in?
21st.BIO invests in Healthcare, Consumer Goods, Materials, Automotive, Renewable Energy and Agriculture, and is based in Søborg, Denmark. 21st.BIO is listed as a venture capital in the ConnectSafely investor database.
What stage does 21st.BIO invest at?
21st.BIO backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does 21st.BIO invest in?
21st.BIO invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at 21st.BIO?
Team members listed for 21st.BIO include Thomas Kabel (Group CFO) and Henrik Geertz-Hansen (Executive Team Member, Chief of Development and R&D Operations).
What companies has 21st.BIO invested in?
21st.BIO's portfolio includes Reshape Biotech and AMSilk.
How do I contact 21st.BIO?
21st.BIO's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
